A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight (ATTAIN-Hypertension) GZL2
Running, not enrolling · Phase 3 · Has a placebo group
Conditions studied: Hypertension
In brief
GZL2 is an independent study conducted under the GZPL master protocol. GZL2 study will evaluate the efficacy and safety of orforglipron for treatment of hypertension in participants with obesity or overweight.
Key facts
- Study ID
- NCT06952530
- Run by
- Eli Lilly and Company
- People needed
- 487
- Starts
- 2025-04-30
- Expected to finish
- 2027-09-01
- Last updated by the study team
- 2026-05-29
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- refer to the GZPL master protocol study for screening eligibility.
You may not qualify if…
- refer to the GZPL master protocol study for screening eligibility.
Where it is running
- Valley Clinical Trials, Inc. — Covina, California, United States
- Valley Clinical Trials, Inc. — Northridge, California, United States
- Chase Medical Research, LLC — Waterbury, Connecticut, United States
- Excel Medical Clinical Trials — Boca Raton, Florida, United States
- Care Access - Brandon — Brandon, Florida, United States
- Northeast Research Institute - Downtown Office — Jacksonville, Florida, United States
- Peace River Cardiovascular Center — Port Charlotte, Florida, United States
- East-West Medical Research Institute — Honolulu, Hawaii, United States
- Sinai Hospital Of Baltimore — Baltimore, Maryland, United States
- Ascension Saint Agnes Heart Care — Baltimore, Maryland, United States
- Lucida Clinical Trials — New Bedford, Massachusetts, United States
- Arcturus Healthcare , PLC, Troy Internal Medicine Research Division — Troy, Michigan, United States
- StudyMetrix Research — City of Saint Peters, Missouri, United States
- Excel Clinical Research, LLC — Las Vegas, Nevada, United States
- Palm Research Center Sunset — Las Vegas, Nevada, United States
- Rochester Clinical Research, LLC — Rochester, New York, United States
- Remington-Davis, Inc — Columbus, Ohio, United States
- Advanced Research Institute - Tigard — Tigard, Oregon, United States
- Care Access - Mauldin — Mauldin, South Carolina, United States
- Dallas Heart and Vascular Consultants, PA — Duncanville, Texas, United States
- Texas Institute of Cardiology, PA — McKinney, Texas, United States
- North Hills Family Medicine/North Hills Medical Research — North Richland Hills, Texas, United States
- Advanced Research Institute — Ogden, Utah, United States
- Carient Heart & Vascular - Manassas — Manassas, Virginia, United States
- Elite Clinical Studies, LLC — Phoenix, Arizona, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.